Business
Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data
BERLIN, Aug. 26, 2019 /PRNewswire/ -- At EUROISMAR 2019 (https://conference.euroismar2019.org), Bruker Corporation (Nasdaq: BRKR) today announced the world's

About this update from Bruker Corporation
[{"type":"text","content":"BERLIN, Aug. 26, 2019 /PRNewswire/ -- At EUROISMAR 2019 (https://conference.euroismar2019.org), Bruker Corporation (Nasdaq: BRKR) today announced the world's first 1.2 GHz high-resolution, protein nuclear magnetic resonance (NMR) data. Two 1.2 GHz superconducting magnets have now reached full field at Bruker's Swiss magnet factory, setting the world record for stable, homogeneous NMR magnets for high-resolution and solid-state protein NMR applications in structural biology and for the study of intrinsically disordered proteins (IDPs). \nAt EUROISMAR 2019, Bruker and its scientific collaborators are presenting 1.2 GHz high-resolution NMR data that has been acquired using a new 1.2 GHz 3 mm triple-inverse TCI CryoProbe. Bruker's unique 1.2 GHz ultra-high field NMR magnets utilize a novel hybrid design with high-temperature superconductor (HTS) inserts inside advanced, low-temperature superconductor (LTS) outserts, which together provide the extremely demanding stability and homogeneity for high-resolution protein NMR. \nProfessors Lucia Banci and Claudio Luchinat at the University of Florence, Italy, are expected to be the first customers to receive a 1.2 GHz NMR spectrometer, once further systems development and factory testing has been completed, a process that is expected to take several more months. After initial data acquisition of CERM test samples on one of the 1.2 GHz systems, they stated: \"At Bruker's UHF facility in Switzerland, high resolution spectra have been acquired on alpha-synuclein, which is an intrinsically disordered protein that has been linked to diseases such as Alzheimer's and Parkinson's. In addition, we have also been able to review first 1.2 GHz NMR spectra of a protein which is associated with several types of cancer. Without a doubt, the improved resolution of the 1.2 GHz instrument – made possible by the increased dispersion at high magnetic fields – will help to advance important fields of research, such as structural biology. We look forward to receiving the 1.2 GHz NMR spectrometer in our laboratory once final developments and factory evaluation have been completed.\"\nDr. Falko Busse, Group President of Bruker BioSpin, said: \"The new 1.2 GHz system is a technological revolution that will enable new molecular and cell biology discoveries. We value the trust our ultra-high field NMR customers plac...